“Holidays” for osteoporosis drugs: A case-based approach

• A “drug holiday” can be considered for patients at low fracture risk; • It is optimal after completion of five years of alendronate and three years of zoledronic acid or risedronate use; • The “drug holiday” strategy should not be implemented for denosumab, estrogen, SERMs or teriparatide....

Descripción completa

Detalles Bibliográficos
Autores principales: Anagnostis, Panagiotis, Paschou, Stavroula A., Kenanidis, Eustathios, Lambrinoudaki, Irene, Potoupnis, Michael, Tsiridis, Eleftherios, Goulis, Dimitrios G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580330/
https://www.ncbi.nlm.nih.gov/pubmed/31431887
http://dx.doi.org/10.1016/j.crwh.2019.e00127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580330/
https://www.ncbi.nlm.nih.gov/pubmed/31431887
http://dx.doi.org/10.1016/j.crwh.2019.e00127

Ejemplares similares